PEN-RAFA VK FORTE

Maa: Israel

Kieli: englanti

Lähde: Ministry of Health

Osta se nyt

Pakkausseloste Pakkausseloste (PIL)
04-12-2018

Aktiivinen ainesosa:

PHENOXYMETHYLPENICILLIN AS POTASSIUM

Saatavilla:

RAFA LABORATORIES LTD

ATC-koodi:

J01CE02

Lääkemuoto:

POWDER FOR SYRUP

Koostumus:

PHENOXYMETHYLPENICILLIN AS POTASSIUM 250 MG / 5 ML

Antoreitti:

PER OS

Prescription tyyppi:

Required

Valmistaja:

SANDOZ GmbH, AUSTRIA

Terapeuttinen ryhmä:

PHENOXYMETHYLPENICILLIN

Terapeuttinen alue:

PHENOXYMETHYLPENICILLIN

Käyttöaiheet:

Treatment of infections caused by susceptible micro-organisms.

Valtuutus päivämäärä:

2022-09-30

Pakkausseloste

                                1
Patient Leaflet According to the Pharmacists' Regulations
(Preparations) - 1986
This medicine requires a physician's prescription
Please read the entire leaflet carefully before using your medication
PEN-RAFA VK 500 CAPLETS
PEN-RAFA VK FORTE POWDER FOR PREPARING 60 ML SYRUP
COMPOSITION:
PEN-RAFA VK 500 CAPLETS
Active ingredient:
Each caplet contains: Penicillin V (as potassium) 500mg
Inactive ingredients:
Magnesium stearate, macrogol 6000, povidone, talc, hypromellose,
titanium dioxide
PEN-RAFA VK FORTE POWDER FOR PREPARING SYRUP
Active ingredient:
Each prepared teaspoon of syrup (5 ml) contains:
Penicillin V (as potassium) 250mg
Inactive ingredients:
Simethicone, saccharin sodium, sodium benzoate, citric acid anhydrous,
aspartame, carmellose
sodium, strawberry flavouring powdered, raspberry flavouring powdered,
trisodium citrate
anhydrous, sucrose
Each teaspoon contains 15 mg sodium, 1.5 g sugar.
THERAPEUTIC ACTIVITY
:
This medicine is indicated for the treatment of infections caused by
organisms susceptible
to penicillin.
THERAPEUTIC GROUP
:
An antibiotic of the penicillin group.
WHEN SHOULD THIS MEDICINE NOT BE USED?
Do not use this medicine if you are sensitive to penicillin,
cephalosporins or
penicillamine.
Do not use this medicine if you are sensitive to any of its
ingredients.
DO NOT TAKE THIS MEDICINE WITHOUT CONSULTING A DOCTOR BEFORE STARTING
TREATMENT:
If you are pregnant or breastfeeding; if you suffer or have suffered
in the past from
impaired function of the: respiratory tract (e.g. asthma), liver,
kidney/urinary tract,
digestive system (e.g. colitis), or if you suffer or have suffered in
the past from any kind
of allergy.
2
WARNINGS
:
_ _
The syrup contains the sweetener aspartame, which may harm patients
who have
phenylketonuria.
Do not use this medicine frequently, or for a long period, without
consulting a physician.
If you are sensitive to any foods or medications notify your physician
before starting
treatment.
DRUG INTERACTIONS
:
If you are taking any other medications or if you have recent
                                
                                Lue koko asiakirja
                                
                            

Asiakirjat muilla kielillä

Pakkausseloste Pakkausseloste arabia 04-12-2018
Pakkausseloste Pakkausseloste heprea 04-12-2018

Etsi tähän tuotteeseen liittyviä ilmoituksia

Näytä asiakirjojen historia